The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA)
1 other identifier
interventional
22
1 country
2
Brief Summary
This investigation is designed to evaluate the performance as well as the patients overall acceptance of the mask.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2016
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 5, 2016
CompletedFirst Posted
Study publicly available on registry
September 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedApril 4, 2017
April 1, 2017
4 months
September 5, 2016
April 2, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Ease of use
Subjective questionnaire
2 weeks in home
Acceptability
Subjective questionnaire
2 weeks in home
Secondary Outcomes (1)
Objective leak data
2 weeks in home
Study Arms (1)
F&P Deimos Nasal Pillows Mask
EXPERIMENTALParticipants to use nasal pillows mask in-home for 2 weeks.
Interventions
Investigative Nasal Pillows Mask to be used for OSA therapy
Eligibility Criteria
You may qualify if:
- Adult (18+ years of age)
- Able to give consent
- Apnea hypopnea Index (AHI)≥ 5 on diagnostic night
- Prescribed PAP for OSA
- Existing nasal pillows user
You may not qualify if:
- Inability to give consent
- Patients who are in a coma or a decreased level of consciousness
- Anatomical or physiological conditions making automatic positive airway pressure (APAP) therapy inappropriate (e.g. unconsolidated facial structure)
- Commercial drivers who are investigated by New Zealand Transport Agency
- Current diagnosis of carbon dioxide (CO2) retention
- Pregnant or may think they are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Fisher and Paykel Healthcare
Auckland, 2013, New Zealand
Hawkes Bay Fallen Soldiers' Memorial Hospital
Hastings, 4120, New Zealand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Gunson, Bsc PgDip
Sponsor Employee
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2016
First Posted
September 9, 2016
Study Start
September 1, 2016
Primary Completion
January 1, 2017
Study Completion
March 1, 2017
Last Updated
April 4, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share
For product development purposes only. Data will be deidentified.